DaVita (NYSE: DVA)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
DaVita Returns vs. S&P
|1 Year||5 Year||5 Year Annualized||Since IPO|
DaVita Company Info
The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.
News & Analysis
Warren Buffett loves to own cash-generating "toll bridge" companies. DaVita qualifies on both counts.
These unstoppable companies can succeed in pretty much any economic condition.
Based on how big a slice of the pie is owned, these could be viewed as Warren Buffett's favorite stocks.
There are several healthcare companies in Berkshire Hathaway's portfolio, but only one in its top 10 holdings.
These names offer growth potential along with income.
These stocks have not yet finished moving higher.
Many Warren Buffett stocks remain buys.
Berkshire's latest 13F filings were released earlier this month.
DVA earnings call for the period ending December 31, 2022.
DVA earnings call for the period ending September 30, 2022.
DVA earnings call for the period ending June 30, 2022.
DVA earnings call for the period ending March 31, 2022.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.